Matrix metalloproteinase inhibitors

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Investigational new drugs

• Publication date

  1997-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1023/A:1005722729132PMID 9195290
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Type IV collagenases in invasive tumors

  2005cited by this paper
• The role of tissue inhibitor of metalloproteinase-1 in specific aspects of cancer progression and reproduction

  2005cited by this paper
• Expression of tissue inhibitors of metalloproteinases: negative regulators of human glioblastoma invasion in vivo

  2004cited by this paper
• Phase I trial of a novel matrix metalloproteinase inhibitor batimastat (BB-94) in patients with advanced cancer

  2004cited by this paper
• Recent advances in matrix metalloproteinase inhibitor research

  1996cited by this paper
• Increased expression of matrix metalloproteinase‐II in experimental liver fibrosis in rats

  1995cited by this paper
• Identification and characterization of human tissue inhibitor of metalloproteinase-3 and detection of three additional metalloproteinase inhibitor activities in extracellular matrix.

  1995cited by this paper
• Human neutrophil collagenase (MMP-8), identified in bronchiectasis BAL fluid, correlates with severity of disease.

  1995cited by this paper
• Gelatinase A activity directly modulates melanoma cell adhesion and spreading.

  1995cited by this paper
• Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcinoma metastasis models.

  1995cited by this paper
• Immunolocalisation studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo- and rheumatoid arthritis.

  1995cited by this paper
• The C-terminal Region of Membrane Type Matrix Metalloproteinase Is a Functional Transmembrane Domain Required for Pro-gelatinase A Activation (*)

  1995cited by this paper
• Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma.

  1995cited by this paper
• Increased levels of stromelysin-1 and tissue inhibitor of metalloproteinases-1 in sera from patients with rheumatoid arthritis.

  1995cited by this paper
• Activated gelatinase-B (MMP-9) and urokinase-type plasminogen activator in synovial fluids of patients with arthritis. Correlation with clinical and experimental variables of inflammation.

  1995cited by this paper
• Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases.

  1995cited by this paper
• Matrix metalloproteinase inhibitors: a novel class of anticancer agents.

  1995cited by this paper
• Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas.

  1995cited by this paper
• Identification of the Second Membrane-type Matrix Metalloproteinase (MT-MMP-2) Gene from a Human Placenta cDNA Library

  1995cited by this paper
• Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).

  1995cited by this paper
• Human Macrophage Metalloelastase. GENOMIC ORGANIZATION, CHROMOSOMAL LOCATION, GENE LINKAGE, AND TISSUE-SPECIFIC EXPRESSION (*)

  1995cited by this paper
• Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: implications for bone resorption.

  1995cited by this paper
• Differential expression of matrix-metalloproteinase-1 and -2 genes in normal and fibrotic human liver.

  1994cited by this paper
• Inhibition of the metastatic spread and growth of B16‐BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor

  1994cited by this paper
• Effect of tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell line.

  1994cited by this paper
• TIMP‐2 Expression Modulates Human Melanoma Cell Adhesion and Motility

  1994cited by this paper
• Stromelysin-3 in stromal tissue as a control factor in breast cancer behavior.

  1994cited by this paper
• Elastolytic metalloproteinases produced by human mononuclear phagocytes. Potential roles in destructive lung disease.

  1994cited by this paper
• Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1.

  1994cited by this paper
• SERUM LEVELS OF A TISSUE INHIBITOR OF METALLOPROTEINASES‐1 (TIMP‐1) IN BLADDER CANCER PATIENTS

  1994cited by this paper
• Enhanced expression of tissue inhibitor of metalloproteinase‐2 (TIMP‐2) in the stroma of breast carcinomas correlates with tumor recurrence

  1994cited by this paper
• Type‐IV collagenase and tissue inhibitor of metalloproteinase in ovarian cancer tissues

  1994cited by this paper
• Prognosis of gastric carcinoma revealed by interactions between tumor cells and basement membrane.

  1994cited by this paper
• Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues.

  1994cited by this paper
• Inhibition of angiogenesis by tissue inhibitor of metalloproteinase

  1994cited by this paper
• Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice.

  1994cited by this paper
• Cloning and Characterization of Human Tissue Inhibitor of Metalloproteinases-3

  1994cited by this paper
• Structure-function relationships in the tissue inhibitors of metalloproteinases.

  1994cited by this paper
• Interstitial collagenase is required for angiogenesis in vitro.

  1994cited by this paper
• Plasma Assay of Matrix Metalloproteinases (MMPs) and MMP‐Inhibitor Complexes in Cancer

  1994cited by this paper
• Stromelysin‐3 in stromal tissue as a control factor in breast cancer behavior

  1994cited by this paper
• Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas.

  1994cited by this paper
• Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues.

  1994cited by this paper
• Expression and activity of MMPS and their regulators in ovarian cancer

  1994cited by this paper
• Distribution of the matrix metalloproteinases stromelysin, gelatinases A and B, and collagenase in Crohn's disease and normal intestine.

  1994cited by this paper
• Serum metalloproteinases and their inhibitors: markers for malignant potential.

  1994cited by this paper
• Calcium influx modulates expression of matrix metalloproteinase-2 (72-kDa type IV collagenase, gelatinase A).

  1994cited by this paper
• Connective Tissue Degradation in Health and Periodontal Disease and the Roles of Matrix Metalloproteinases and Their Natural Inhibitors

  1994cited by this paper
• Gene encoding a novel murine tissue inhibitor of metalloproteinases (TIMP), TIMP‐3, is expressed in developing mouse epithelia, cartilage, and muscle, and is located on mouse chromosome 10

  1994cited by this paper
• Matrix metalloproteinases in abdominal aortic aneurysm: characterization, purification, and their possible sources.

  1994cited by this paper
• Serum levels of collagenase, stromelysin-1, and TIMP-1. Age- and sex-related differences in normal subjects and relationship to the extent of joint involvement and serum levels of antigenic keratan sulfate in patients with osteoarthritis.

  1994cited by this paper
• Treatment of Destructive Arthritic Disorders with MMP Inhibitors

  1994cited by this paper
• Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9.

  1993cited by this paper
• Mechanistic studies on the inhibition of stromelysin by a peptide phosphonamidate.

  1993cited by this paper
• A phase I study of intravenous bryostatin 1 in patients with advanced cancer.

  1993cited by this paper
• A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts.

  1993cited by this paper
• M(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer.

  1993cited by this paper
• Bryostatin 1: will the oceans provide a cancer cure?

  1993cited by this paper
• Extracellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasis

  1993cited by this paper
• Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production.

  1993cited by this paper
• Phase I study of bryostatin 1: assessment of interleukin 6 and tumor necrosis factor alpha induction in vivo. The Cancer Research Campaign Phase I Committee.

  1993cited by this paper
• Localization by in situ hybridization of mRNAs encoding stromelysin 3 and tissue inhibitors of metallo-proteinases TIMP-1 and TIMP-2 in human head and neck carcinomas.

  1993cited by this paper
• Demonstration of interstitial collagenase in abdominal aortic aneurysm disease.

  1993cited by this paper
• Matrix metalloproteinases: a review.

  1993cited by this paper
• Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small-cell lung carcinoma.

  1993cited by this paper
• Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions.

  1993cited by this paper
• Type IV collagenase/gelatinase (MMP-2) is not increased in plasma of patients with cancer.

  1992cited by this paper
• Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases.

  1992cited by this paper
• Molecular determinants of growth, angiogenesis, and metastases in breast cancer.

  1992cited by this paper
• Preclinical evaluation of bryostatin as an anticancer agent against several murine tumor cell lines: in vitro versus in vivo activity.

  1992cited by this paper
• Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma.

  1991cited by this paper
• Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma.

  1991cited by this paper
• Growth factors in development, transformation, and tumorigenesis.

  1991cited by this paper
• Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation.

  1991cited by this paper
• Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma.

  1991cited by this paper
• The current status of targeting tumour vasculature as a means of cancer therapy: an overview.

  1991cited by this paper
• Tumor interactions with the vasculature: angiogenesis and tumor metastasis.

  1990cited by this paper
• Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases.

  1990cited by this paper
• Development of angiogenesis inhibitors for clinical applications.

  1990cited by this paper
• What is the evidence that tumors are angiogenesis dependent?

  1990cited by this paper
• Metalloproteinases and their inhibitors in matrix remodeling.

  1990cited by this paper
• Basement membrane collagen-degrading activity from a malignant tumor is inhibited by anthracycline antibiotics.

  1990cited by this paper
• Human fibroblast collagenase-alpha-macroglobulin interactions. Localization of cleavage sites in the bait regions of five mammalian alpha-macroglobulins.

  1989cited by this paper
• Inhibition of purified collagenase from alkali-burned rabbit corneas.

  1989cited by this paper
• Tumor promoter-induced membrane-bound protein kinase C regulates hematogenous metastasis.

  1988cited by this paper
• Angiogenic factors.

  1987cited by this paper
• Regulation of the expression of tissue inhibitor of metalloproteinases and collagenase by retinoids and glucocorticoids in human fibroblasts.

  1987cited by this paper
• Bryostatin induces changes in protein kinase C location and activity without altering c-myc gene expression in human promyelocytic leukemia cells (HL-60).

  1987influential reference
• Endothelial-cell proliferation in experimental tumours.

  1982cited by this paper
• Proliferation kinetics of endothelial and tumour cells in three mouse mammary carcinomas

  1982cited by this paper
• The interaction of α2-macroglobulin with proteinases. Characteristics and specificity of the reaction, and a hypothesis concerning its molecular mechanism

  1973cited by this paper
• The interaction of alpha 2-macroglobulin with proteinases. Characteristics and specificity of the reaction, and a hypothesis concerning its molecular mechanism.

  1973cited by this paper

• Kaempferol Inhibits MMP-1-Mediated Migration and Invasion in Gemcitabine-Resistant Pancreatic Cancer Cells

  2026cites this paper
• Molecular mechanisms underlying the inhibition of cell migration and invasion in endometriosis: Advances in pharmacological research (Review)

  2025cites this paper
• TRPC6 effects on albumin permeation, nephrin shedding, and apoptosis in podocytes: Role of calcineurin and metalloproteases

  2025cites this paper
• The Influence of Injectable Platelet-Rich Fibrin on the Clinical Parameters and the Levels of MMP-8 in the GCF in Non-Surgical Treatment of Periodontitis—Randomized Trial

  2025cites this paper
• Matrix Metalloproteinases and Their Inhibitors in the Pathogenesis of Epithelial Differentiation, Vascular Disease, Endometriosis, and Ocular Fibrotic Pterygium

  2025cites this paper
• Tissue inhibitor of metalloproteinase 1 as a biomarker of venous invasion in pancreatic ductal adenocarcinoma.

  2025cites this paper
• The role of MMPs in intracerebral hemorrhage

  2025cites this paper
• OSMRβ-mediated signals on resident fibroblasts restore healing in diabetic skin wounds through promoting angiogenesis and granulation tissue formation

  2025cites this paper
• Design and Synthesis of Hydroxamate-Based Matrix Metalloproteinase-2 Inhibitors for Anti-Photoaging

  2025cites this paper
• Astragalus membranaceus Extract Attenuates Inflammatory Cytokines and Matrix-Degrading Enzymes in Human Chondrocytes: A Novel Nutraceutical Strategy for Joint Health

  2025cites this paper
• Plant-Derived Lapachol Analogs as Selective Metalloprotease Inhibitors Against Bothrops Venom: A Review

  2025cites this paper
• Unraveling the Role of the Wnt Pathway in Hepatocellular Carcinoma: From Molecular Mechanisms to Therapeutic Implications

  2025cites this paper
• Therapeutic potential of inhibitors of gelatinases MMP-2 and MMP-9 for the treatment of breast cancer.

  2025cites this paper
• Unveiling structural components of dibenzofuran-based MMP-12 inhibitors: a comparative classification-dependent analysis with molecular docking-based virtual screening and molecular dynamics simulation

  2025cites this paper
• An overview of matrix metalloproteinase-12 in multiple disease conditions, potential selective inhibitors, and drug designing strategies.

  2024cites this paper
• MCQ Corner - Oncology

  2024cites this paper
• Breaking the Cycle: Matrix Metalloproteinase Inhibitors as an Alternative Approach in Managing Tuberculosis Pathogenesis and Progression.

  2024cites this paper
• Antimetastatic activity of (arene)ruthenium(II) complex of 4-aryl-4H-naphthopyran.

  2024cites this paper
• Metalloproteinases are involved in the regulation of prenatal tooth morphogenesis.

  2024cites this paper
• Research progress of ginger in the treatment of gastrointestinal tumors

  2023cites this paper
• An updated patent review of matrix metalloproteinase (MMP) inhibitors (2021-present)

  2023cites this paper
• SKI-1/S1P Facilitates SARS-CoV-2 Spike Induced Cell-to-Cell Fusion via Activation of SREBP-2 and Metalloproteases, Whereas PCSK9 Enhances the Degradation of ACE2

  2023cites this paper
• Ginsenoside Compound K Ameliorates Osteoarthritis by Inhibiting the Chondrocyte Endoplasmic Reticulum Stress-Mediated IRE1α-TXNIP-NLRP3 Axis and Pyroptosis.

  2023cites this paper
• Cell surface associated protein mucin 15 (MUC15) is elevated in preeclampsia.

  2023cites this paper
• Novel Matrix Metalloproteinase-9 (MMP-9) Inhibitors in Cancer Treatment

  2023cites this paper
• New Derivatives of N-Hydroxybutanamide: Preparation, MMP Inhibition, Cytotoxicity, and Antitumor Activity

  2023cites this paper
• Challenges and Opportunities Associated With Drug Delivery for the Treatment of Solid Tumors

  2023cites this paper
• SARS-CoV-2 and Epstein–Barr Virus-like Particles Associate and Fuse with Extracellular Vesicles in Virus Neutralization Tests

  2023cites this paper
• Potential Therapeutic Targets of Quercetin in the Cutaneous Melanoma Model and Its Cellular Regulation Pathways: A Systematic Review

  2023cites this paper
• HB‐EGF promotes progenitor cell proliferation and sensory neuron regeneration in the zebrafish olfactory epithelium

  2023cites this paper
• Natural Plant Compounds: Does Caffeine, Dipotassium Glycyrrhizinate, Curcumin, and Euphol Play Roles as Antitumoral Compounds in Glioblastoma Cell Lines?

  2022cites this paper
• Inflammation and Invasion in Oral Squamous Cell Carcinoma Cells Exposed to Electronic Cigarette Vapor Extract

  2022cites this paper
• Elevated Pre-Treatment Serum MMP-7 Levels Are Associated with the Presence of Metastasis and Poor Survival in Upper Tract Urothelial Carcinoma

  2022cites this paper
• Selective Inhibitors of Medium-Size S1' Pocket Matrix Metalloproteinases: A Stepping Stone of Future Drug Discovery.

  2022cites this paper
• HPMA copolymer-collagen hybridizing peptide conjugates targeted to breast tumor extracellular matrix.

  2022cites this paper
• Circulating LIGHT (TNFSF14) and Interleukin-18 Levels in Sepsis-Induced Multi-Organ Injuries

  2022cites this paper
• Insights Into the Role of Matrix Metalloproteinases in Cancer and its Various Therapeutic Aspects: A Review

  2022cites this paper
• Recombinant protein drugs-based intra articular drug delivery systems for osteoarthritis therapy.

  2022cites this paper
• Initial detachment of the mouse oocyte from the zona pellucida is mediated by metallopeptidase activity

  2022cites this paper
• Clinical management of snakebite envenoming: Future perspectives

  2021cites this paper
• Discovery of GLPG1972/S201086, a Potent, Selective, and Orally Bioavailable ADAMTS-5 Inhibitor for the Treatment of Osteoarthritis.

  2021cites this paper
• Old and New Players of Inflammation and Their Relationship With Cancer Development

  2021cites this paper
• Harnessing Extracellular Matrix Biology for Tumor Drug Delivery

  2021cites this paper
• The Charming World of the Extracellular Matrix: A Dynamic and Protective Network of the Intestinal Wall

  2021cites this paper
• SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation

  2021cites this paper
• Elevation of Circulating LIGHT (TNFSF14) and Interleukin-18 Levels in Sepsis-Induced Multi-Organ Injuries

  2021cites this paper
• Mechanisms of Lower Extremity Vein Dysfunction in Chronic Venous Disease and Implications in Management of Varicose Veins.

  2021cites this paper
• Combined Radiochemotherapy: Metalloproteinases Revisited

  2021cites this paper
• Journey of anthraquinones as anticancer agents – a systematic review of recent literature

  2021cites this paper
• Alternative therapeutic strategy for existing aortic aneurysms using mesenchymal stem cell–derived exosomes

  2021cites this paper
• Role of HSP90 in Cancer

  2021cites this paper
• Plasma and Serum Proteins Bound to Nanoceria: Insights into Pathways by which Nanoceria may Exert Its Beneficial and Deleterious Effects In Vivo

  2020cites this paper
• The Role of Extracellular Proteases in Tumor Progression and the Development of Innovative Metal Ion Chelators That Inhibit Their Activity

  2020cites this paper
• The Role of Matrix Metalloproteinases in Periodontal Disease

  2020cites this paper
• Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview.

  2020cites this paper
• Matrix metalloproteinase inhibitor and sunscreen effective compounds from Rumex crispus L.: isolation, identification, bioactivity and molecular docking study.

  2020cites this paper
• Outline of gelatinase inhibitors as anti-cancer agents: A patent mini-review for 2010-present.

  2020cites this paper
• Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance

  2020cites this paper
• Unravelling the Network of Nuclear Matrix Metalloproteinases for Targeted Drug Design

  2020cites this paper
• Early disruption of the alveolar-capillary barrier in a ricin-induced ARDS mouse model: neutrophil-dependent and -independent impairment of junction proteins.

  2019cites this paper
• Thiosemicarbazones suppress expression of the c-Met oncogene by mechanisms involving lysosomal degradation and intracellular shedding

  2019cites this paper
• The role of matrix metalloproteinases in osteoarthritis pathogenesis: An updated review.

  2019cites this paper
• Matrix degradation regulates osteoblast protrusion dynamics and individual migration.

  2019cites this paper
• Role of Tissue Inhibitor of Matrix Metalloproteinase-1 in the Development of Hypersensitivity Using an Animal Model of Cutaneous Inflammation

  2019cites this paper
• Inhibition of MMPs and ADAM/ADAMTS.

  2019cites this paper
• Efficacy and safety of gemcitabine plus anti-angiogenesis therapy for advanced pancreatic cancer: a systematic review and meta-analysis of clinical randomized phase III trials

  2019cites this paper
• Effect of Phosphorylated Chitosan on Dentin Erosion: An in vitro Study

  2018cites this paper
• Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures Into Future Successes

  2018cites this paper
• Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.

  2018cites this paper
• To shift or not to shift: Low density lipoprotein receptor-related protein 1 and the plasminogen activators gate phase shifting in the mammalian circadian clock

  2018cites this paper
• Disruption of IGF-1R signaling by a novel quinazoline derivative, HMJ-30, inhibits invasiveness and reverses epithelial-mesenchymal transition in osteosarcoma U-2 OS cells

  2018cites this paper
• Tumor cell density regulates matrix metalloproteinases for enhanced migration

  2018cites this paper
• Matrix Metalloproteinases in Remodeling of Lower Extremity Veins and Chronic Venous Disease.

  2017cites this paper
• Rational Design of Short Peptide-Based Hydrogels with MMP-2 Responsiveness for Controlled Anticancer Peptide Delivery.

  2017cites this paper
• Enzymes involved in tumor-driven angiogenesis: A valuable target for anticancer therapy.

  2017cites this paper
• Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.

  2017cites this paper
• Multiple receptor-ligand based pharmacophore modeling and molecular docking to screen the selective inhibitors of matrix metalloproteinase-9 from natural products

  2017cites this paper
• Targeting the Hemopexin-like Domain of Latent Matrix Metalloproteinase-9 (proMMP-9) with a Small Molecule Inhibitor Prevents the Formation of Focal Adhesion Junctions

  2017cites this paper
• Expression of Matrix Metalloproteinases-2/-9 is Associated With Microvessel Density in Pancreatic Cancer

  2017cites this paper
• Variations in biocorona formation related to defects in the structure of single walled carbon nanotubes and the hyperlipidemic disease state

  2017cites this paper
• Microwave-Assisted Facile Synthesis, Anticancer Evaluation and Docking Study of N-((5-(Substituted methylene amino)-1,3,4-thiadiazol-2-yl)methyl) Benzamide Derivatives

  2017cites this paper
• Gelatinases and their tissue inhibitors are associated with oxidative stress: a potential set of markers connected with male infertility.

  2016cites this paper
• The Treatment of Breast Cancer Tumor Growth and Metastasis With an Anti-MMP 9 DNAzyme

  2016cites this paper
• Studying cancer metastasis: Existing models, challenges and future perspectives.

  2016cites this paper
• THE ROLE OF CHITOSAN IN AKT KINASE REGULATION ACTIVITY

  2016cites this paper
• Analysis and Synthesis of Novel Inhibitors of MMPs and other Biological Targets

  2016cites this paper
• Pharmacodynamic considerations in the use of matrix metalloproteinase inhibitors in cancer treatment

  2016cites this paper
• A study on quantitative structure–activity relationship and molecular docking of metalloproteinase inhibitors based on L-tyrosine scaffold

  2015cites this paper
• In vitro inhibitory effects of terpenoids from Chloranthus multistachys on epithelial-mesenchymal transition via down-regulation of Runx2 activation in human breast cancer.

  2015cites this paper
• Computational model of collagen turnover in carotid arteries during hypertension

  2015cites this paper
• Matrix metalloproteinases: potential therapeutic target for diabetic neuropathic pain

  2015cites this paper
• Matrix Metalloproteinases as Regulators of Vein Structure and Function: Implications in Chronic Venous Disease

  2015cites this paper
• Kinetic characterization of 4,4′-biphenylsulfonamides as selective non-zinc binding MMP inhibitors

  2015cites this paper
• Effects of Fengbaisan (丰白散) on the expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in lung tissue of rats with chronic obstructive pulmonary disease

  2014cites this paper
• Anti-Cancer Activity And Anti-Proliferation Ant Nests Flavonoid Fraction Test (Myrmecodya Pendans) Human Tongue Cancer Cells In Sp-C1

  2014cites this paper
• Acetyl-L-Carnitine Prevents Methamphetamine-Induced Structural Damage on Endothelial Cells via ILK-Related MMP-9 Activity

  2014cites this paper
• A novel matrix metalloproteinase-2 inhibitor triazolylmethyl aziridine reduces melanoma cell invasion, angiogenesis and targets ERK1/2 phosphorylation

  2014cites this paper
• The use of a three-dimensional cell culture model to investigate host-pathogen interactions of Francisella tularensis in human lung epithelial cells.

  2014cites this paper
• Participación de las metaloproteinasas de matriz extracelular en la EPOC

  2014cites this paper
• Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in the tumors of central nervous system (CNS)

  2014cites this paper